Copyright ©The Author(s) 2015.
World J Hepatol. Jul 18, 2015; 7(14): 1866-1874
Published online Jul 18, 2015. doi: 10.4254/wjh.v7.i14.1866
Figure 1
Figure 1 Contrast-enhanced ultrasound performed after 1 mo in a 71-year-old man treated with trans-catheter arterial chemo-embolisation: On the left side complete necrosis is depicted as an avascular area; on the right side B-mode imaging of the treated area.
Figure 2
Figure 2 Target hepatic lesion in a 65-year-old man treated with sorafenib: Clinical example of responder on dynamic contrast-enhanced ultrasound. A: Contrast-enhanced ultrasound with corresponding time-intensity curve at baseline; B: Fifteen days after onset of sorafenib therapy, contrast-enhanced ultrasound revealed an increase in tumour necrosis with drastic reduction of tumour perfusion parameters shown by contrast enhancement pattern and corresponding time-intensity curve.